Eli Lilly is trading 4.1% down today at $31,920.00 as the healthcare sector slides following a full-year profit outlook cut from HCA Healthcare.
- The downward move is driven by broad sector weakness after HCA Healthcare's guidance revision pressured healthcare names generally.
- The stock is moving against a broadly positive trend in the wider U.S. equity market.
- No fresh, company-specific negative catalysts have been identified for Eli Lilly today, with recent news focused on Alzheimer’s presentations at AAIC 2026.